March 13, 2012
When you think of Botox injections, you probably think of getting rid of unwanted wrinkles around the eyes or forehead, but recently the US Food and Drug Administration (FDA) approved using the injections to help patients with neurological conditions who suffer from incontinence, or an overactive bladder.
December 4, 2014
…“This will be the generation that stops HIV/AIDS.” When the first clinical reports of AIDS emerged more than 30 years ago, those diagnosed with the then-mysterious disease faced a looming death sentence. Most had just months to live. Kadakia explained how much has changed since them. “This is a very…
February 19, 2020
A team of researchers at the University of California San Diego describe in a new study the successful use of an analysis tool that uses artificial intelligence to identify chemical compounds, including ones with potential benefit as cancer drugs or antibiotics, within seconds.
January 26, 2015
…and help drive therapeutic drug development, researchers at University of California, San Diego School of Medicine developed 3D computer models that show exactly how two PLA2 enzymes extract their substrates from cellular membranes. The new tool is described in a paper published online the week of Jan. 26 by the…
September 9, 2013
…or a history of depression, researchers concluded that the drug does help some of these patients to quit smoking without worsening symptoms of depression or anxiety.
June 16, 2021
Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they’re needed.
May 9, 2024
UC San Diego researchers found that, during the peak of the COVID-19 pandemic, people experiencing homelessness and people who inject drugs in San Diego and Tijuana often did not have access to drinking water, toilets, handwashing and showers.
January 4, 2016
A team of researchers, with the aid of the Gordon supercomputer at the San Diego Supercomputer Center based at UC San Diego, has identified a class of possible antibiotics with the potential to disable previously drug-resistant bacteria.
May 15, 2020
The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A Q&A with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.
September 17, 2012
…order to match each patient to the best available drug for his or her particular tumor.
